At the same time, Liu et al. (2015) reported that Mdivi-1 may be an effective therapeutic agent for spinal cord ischemia–reperfusion injury via activation of large-conductance Ca2+-activated K+ channels as well as reduction of oxidative stress, mitochondrial dysfunction and neuronal apoptosis. Here, LARGE1 is linked to spinal cord ischemia.